U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07659652) titled 'Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease' on June 09.
Brief Summary: Central nervous system (CNS) metastases including breast cancer brain metastases (BCBMs) and leptomeningeal disease (LMD) are common affecting up to 30% of patients with metastatic breast cancer (MBC). The goal of this research is to understand symptom burden and quality of life trajectories in this population and how treatments guide care management decisions.
Study Start Date: June 15
Study Type: OBSERVATIONAL
Condition:
Breast Cancer, Quality of Life
Breast Cancer, Metastatic
Breast Cancer, Metastatic Breast...